Core Insights - Southbound funds increased their holdings in Baize Medical (02609.HK) by 1.6494 million shares on February 13, with a total net increase of 467,400 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net increases in holdings by southbound funds, totaling 8.016 million shares [1] - As of now, southbound funds hold 73.0944 million shares of Baize Medical, representing 5.54% of the company's total issued ordinary shares [1] Company Overview - Baize Medical Group is primarily engaged in investment and provision of medical-related services, focusing on oncology [1] - The company offers comprehensive oncology medical services, including screening, diagnosis, treatment, and rehabilitation [1] - Its business operations encompass hospital services, hospital management, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - Services provided include cancer diagnosis, treatment, rehabilitation, end-of-life care, early cancer screening, cancer vaccination, and health management services for potential healthy populations [1] - The company primarily operates in the Chinese market [1]
佰泽医疗（02609.HK）：2月13日南向资金增持164.94万股